Type 1 IFN signaling is associated with increased Th17 polarization in autoimmune diseases like psoriasis and systemic lupus erythematosus, resulting in the production of IL-22 by Th17 cells.78 This evidence concerns the gene IL22 and systemic lupus erythematosus.